Efficacy of beta-blocking agents in reducing the number of shocks in patients implanted with first-generation...

Area of Science:

• Cardiology
• Pharmacology

Background:

• Patients with implantable cardioverter-defibrillators (ICDs) often experience recurrent ventricular tachyarrhythmias.
• Coronary artery disease and non-ischaemic heart disease are common underlying causes of these arrhythmias.

Purpose of the Study:

• To evaluate the efficacy of beta-blockers in reducing ventricular tachyarrhythmia events in patients with ICDs.
• To compare the rate of defibrillator shocks during periods with and without beta-blocker therapy.

Main Methods:

• A crossover study design was employed in 11 patients who had received ICDs.
• Patients were treated with acebutolol initially, followed by nadolol for long-term therapy.
• A comparison of shock rates was performed during periods with and without beta-blocker administration.

Main Results:

• The monthly rate of defibrillator shocks was significantly lower during beta-blocker treatment (0.12 shocks/month) compared to periods without (1.09 shocks/month).
• Only 4 out of 10 patients received shocks while on beta-blockers, versus all 10 patients when not on the medication.
• A total of 96 shocks were analyzed after excluding 14 potentially inappropriate shocks.

Conclusions:

• Beta-blocker therapy appears effective in preventing severe ventricular tachyarrhythmias in patients with ICDs.
• Further research with advanced ICD memory functions is warranted to confirm these findings.